NCT06104566 · Interventional
Global Trial in APG2575 for Patients With CLL/SLL
CLL/SLL
Study overall: Recruiting · source record updated 18 June 2026.
8 England locations · 8 explicitly recorded as recruiting.
RESEARCH IN ENGLAND
Explore clinical trials with England locations
Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.
230 matching studies · ordered by study identifier.
The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.
NCT06129864 · Interventional
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Study overall: Recruiting · source record updated 3 September 2026.
11 England locations · 9 explicitly recorded as recruiting.
NCT06134401 · Interventional
Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability
Neuromuscular Diseases · Neurodevelopmental Disorders · Cerebral Palsy
Study overall: Not yet recruiting · source record updated 15 October 2024.
2 England locations · 0 explicitly recorded as recruiting.
NCT06205121 · Interventional
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Pulmonary Sarcoidosis
Study overall: Recruiting · source record updated 30 July 2026.
4 England locations · 3 explicitly recorded as recruiting.
NCT06215716 · Interventional
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis · MASH With Fibrosis
Study overall: Recruiting · source record updated 7 August 2026.
9 England locations · 8 explicitly recorded as recruiting.
NCT06216301 · Interventional
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non-small Cell Lung Cancer
Study overall: Recruiting · source record updated 25 June 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT06238622 · Interventional
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Idiopathic Pulmonary Fibrosis · Progressive Pulmonary Fibrosis
Study overall: Recruiting · source record updated 20 August 2026.
10 England locations · 0 explicitly recorded as recruiting.
NCT06252649 · Interventional
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Metastatic Colorectal Cancer
Study overall: Recruiting · source record updated 3 September 2026.
9 England locations · 9 explicitly recorded as recruiting.
NCT06253871 · Interventional
A Phase 1/1b Study of IAM1363 in HER2 Cancers
HER2 Mutation-Related Tumors · HER2 · HER2-positive Breast Cancer · HER2 + Breast Cancer · Brain Metastases From Solid Tumors · Brain Metastases From HER2 and Breast Cancer · CNS Metastases · HER2-Positive Solid Tumors · NSCLC (Non-small Cell Lung Cancer) · HER2-positive Bladder Cancer · HER2-positive Colorectal Cancer · HER2 + Gastric Cancer · HER2-positive Gastroesophageal Cancer
Study overall: Recruiting · source record updated 9 September 2026.
3 England locations · 3 explicitly recorded as recruiting.
NCT06256588 · Interventional
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Neoplasms, Head and Neck
Study overall: Recruiting · source record updated 26 May 2026.
5 England locations · 4 explicitly recorded as recruiting.
NCT06264180 · Interventional
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Advanced Melanoma
Study overall: Recruiting · source record updated 15 July 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT06282575 · Interventional
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Biliary Tract Cancer
Study overall: Recruiting · source record updated 14 July 2026.
4 England locations · 4 explicitly recorded as recruiting.
NCT06286163 · Observational
Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients
Chronic Cough
Study overall: Recruiting · source record updated 7 February 2025.
2 England locations · 2 explicitly recorded as recruiting.
NCT06311708 · Observational
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Arrhythmogenic Right Ventricular Cardiomyopathy
Study overall: Recruiting · source record updated 1 November 2024.
3 England locations · 3 explicitly recorded as recruiting.
NCT06320067 · Interventional
A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
Prostate Cancer Metastatic
Study overall: Recruiting · source record updated 26 September 2025.
18 England locations · 18 explicitly recorded as recruiting.
NCT06324357 · Interventional
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Metastatic Breast Cancer · Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Esophageal Adenocarcinoma · Colorectal Cancer
Study overall: Recruiting · source record updated 6 August 2026.
9 England locations · 7 explicitly recorded as recruiting.
NCT06355583 · Interventional
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
Acute Lymphoblastic Leukaemia · Acute Leukemia of Ambiguous Lineage · Chronic Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndrome · Acute Myeloid Leukemia
Study overall: Recruiting · source record updated 17 April 2025.
8 England locations · 6 explicitly recorded as recruiting.
NCT06357416 · Interventional
The Man Van Project
Prostate Cancer · Urologic Cancer · Urologic Diseases · Bladder Cancer · Diabetes · Hypertension · Mental Health Issue · Alcoholism · Smoking · Renal Cancer · Testis Cancer
Study overall: Recruiting · source record updated 1 May 2024.
1 England locations · 1 explicitly recorded as recruiting.
NCT06357533 · Interventional
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Study overall: Recruiting · source record updated 12 August 2026.
7 England locations · 4 explicitly recorded as recruiting.
NCT06385080 · Interventional
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Study overall: Recruiting · source record updated 28 August 2026.
7 England locations · 6 explicitly recorded as recruiting.
More ways to explore research
This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
How we selected and connected these records
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.